Effect of lipoic acid on expression of angiogenic factors in diabetic rat retina

Clinical and Experimental Ophthalmology

Volumn 40, Issue 1, 2012, Pages

  Lee, Sul Gee ^a   Lee, Chang Gun ^c   Yun, Il Han ^a   Hur, Dae Young ^b   Yang, Jae Wook ^a   Kim, Hyun Woong ^a  

^a The Catholic University of Korea   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Kangnam Hanul Ophthalmic Clinic   (South Korea)

Author keywords

Angiopoietin; Erythropoietin; Superoxide; VEGF

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ERYTHROPOIETIN; HYDROETHIDINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STREPTOZOCIN; THIOCTIC ACID; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYEBALL; HYPERGLYCEMIA; NONHUMAN; PROTEIN EXPRESSION; RAT; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ANGIOGENIC PROTEINS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ERYTHROPOIETIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MALE; NADPH OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDES; THIOCTIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84856665569     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02695.x     Document Type: Article

References (38)

1. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 1998; 43: 245-69.
2. Aiello LP, Gardner TW, King GL etal. Diabetic retinopathy. Diabetes Care 1998; 21: 143-56.
3. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995; 113: 1538-44.
4. Haskins K, Bradley B, Powers K etal. Oxidative stress in type 1 diabetes. Ann N Y Acad Sci 2003; 1005: 43-54.
5. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001; 50: 1938-42.
6. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501.
7. Engerman RL, Kern TS, Larson ME. Nerve conduction and aldose reductase inhibition during 5years of diabetes or galactosaemia in dogs. Diabetologia 1994; 37: 141-4.
8. Beisswenger PJ, Howell SK, Smith K, Szwergold BS. Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 2003; 1637: 98-106.
9. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998; 47: 859-66.
10. Stauble B, Boscoboinik D, Tasinato A, Azzi A. Modulation of activator protein-1 (AP-1)transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells. Eur J Biochem 1994; 226: 393-402.
11. Du XL, Edelstein D, Rossetti L etal. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 2000; 97: 12222-6.
12. Caldwell RB, Bartoli M, Behzadian MA etal. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 2005; 6: 511-24.
13. DeBosch BJ, Baur E, Deo BK, Hiraoka M, Kumagai AK. Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation. J Neurochem 2001; 77: 1157-67.
14. Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal 2005; 7: 1581-87.
15. Saito Y, Geisen P, Uppal A, Hartnett ME. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol Vis 2007; 13: 840-53.
16. Harfouche R, Malak NA, Brandes RP, Karsan A, Irani K, Hussain SN. Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J 2005; 19: 1728-30.
17. Ribatti D, Vacca A, Roccaro AM, Crivellato E, Presta M. Erythropoietin as an angiogenic factor. Eur J Clin Invest 2003; 33: 891-6.
18. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 2004; 264: 85-97.
19. Greene EL, Nelson BA, Robinson KA, Buse MG. Alpha-Lipoic acid prevents the development of glucose-induced insulin resistance in 3T3-L1 adipocytes and accelerates the decline in immunoreactive insulin during cell incubation. Metabolism 2001; 50: 1063-9.
20. Loebstein R, Lehotay DC, Luo X, Bartfay W, Tyler B, Sher GD. Diabetic nephropathy in hypertransfused patients with beta-thalassemia. The role of oxidative stress. Diabetes Care 1998; 21: 1306-9.
21. Bursell SE, Clermont AC, Aiello LP etal. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 1999; 22: 1245-51.
22. Ruhe RC, McDonald RB. Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 2001; 20: 363S-9S. Discussion 81S-83S.
23. Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17: 888-95.
24. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-12.
25. Kowluru RA. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 2003; 52: 818-23.
26. Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 2003; 35: 1491-9.
27. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003; 52: 2346-52.
28. Kowluru RA, Odenbach S. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 2004; 53: 3233-8.
29. Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med 1997; 22: 587-92.
30. Miwa K, Nakamura J, Hamada Y etal. The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract 2003; 60: 1-9.
31. Lu M, Kuroki M, Amano S etal. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998; 101: 1219-24.
32. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999; 274: 15732-9.
33. Okamoto T, Yamagishi S, Inagaki Y etal. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB J 2002; 16: 1928-30.
34. Thurston G, Rudge JS, Ioffe E etal. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6: 460-3.
35. Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003; 111: 431-3.
36. Krantz SB. Erythropoietin. Blood 1991; 77: 419-34.
37. Anagnostou A, Liu Z, Steiner M etal. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci U S A 1994; 91: 3974-8.
38. Watanabe D, Suzuma K, Matsui S etal. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005; 353: 782-92.